The prospects of CRISPR-based genome engineering in the treatment of neurodegenerative disorders
Over the past few decades, as gene discovery methods and sequencing technologies have evolved, many genetic variations that significantly increase the risk of or cause neurodegenerative diseases have been identified. However, knowledge of those pathogenic mutations and subsequent mechanism-focused s...
Main Authors: | Jun Wan Shin, Jong-Min Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-01-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/1756285617741837 |
Similar Items
-
Anti-CRISPR Proteins: Applications in Genome Engineering
by: Lee, Jooyoung
Published: (2020) -
Genome engineering with TALE and CRISPR systems in neuroscience
by: Han B Lee, et al.
Published: (2016-04-01) -
Flavonoids: Potential Candidates for the Treatment of Neurodegenerative Disorders
by: Shweta Devi, et al.
Published: (2021-01-01) -
Redox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders
by: Musbau Adewumi Akanji, et al.
Published: (2021-01-01) -
Gene therapy for neurodegenerative disorders: advances, insights and prospects
by: Wei Chen, et al.
Published: (2020-08-01)